| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma. A diagnostic test accuracy Cochrane review
|
Colli, A.
|
|
|
53 |
S1 |
p. S36
|
artikel
|
| 2 |
Abnormal glycosphingolipid patterns in human cholangiocarcinoma stem-like subsets
|
Mannini, A.
|
|
|
53 |
S1 |
p. S39
|
artikel
|
| 3 |
A challenging case of chronic haemolisys in liver cirrhosis: Spur cell anemia
|
Bevilacqua, M.
|
|
|
53 |
S1 |
p. S24
|
artikel
|
| 4 |
A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
|
Pennisi, G.
|
|
|
53 |
S1 |
p. S27
|
artikel
|
| 5 |
AFP at transplant is associated with a higher risk of HCC recurrence after liver transplantation for patients meeting Milano criteria
|
Magro, B.
|
|
|
53 |
S1 |
p. S37
|
artikel
|
| 6 |
A.I.S.F. 2021: Abstracts evaluation procedure
|
|
|
|
53 |
S1 |
p. S48
|
artikel
|
| 7 |
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism
|
Simeone, I.
|
|
|
53 |
S1 |
p. S36
|
artikel
|
| 8 |
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy
|
Frazzoni, L.
|
|
|
53 |
S1 |
p. S17-S18
|
artikel
|
| 9 |
Analysis of clinical course of portal vein thrombosis in cirrhosis with hepatocellular carcinoma
|
Grasso, M.
|
|
|
53 |
S1 |
p. S43
|
artikel
|
| 10 |
A new model of care involving General Practitioners for HCV elimination in patients with mild liver disease: The experience of Pordenone (Friuli Venezia Giulia)
|
Garlatti Costa, E.
|
|
|
53 |
S1 |
p. S17
|
artikel
|
| 11 |
Angiopoietin-2 associated with NASH in paediatric NAFLD
|
Panera, N.
|
|
|
53 |
S1 |
p. S29
|
artikel
|
| 12 |
A single center, large long-term cohort study of the relations between mutations in Basic-Core-Promoter and pre-C regions of Hepatitis B virus DNA and clinic-pathologic outcome of HBeAg-negative/anti-HBe-positive phase
|
Cavallone, D.
|
|
|
53 |
S1 |
p. S2
|
artikel
|
| 13 |
Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study
|
Coppola, C.
|
|
|
53 |
S1 |
p. S2-S3
|
artikel
|
| 14 |
Changing demographic-clinic-pathologic profiles of newly diagnosed carriers of chronic hepatitis B virus infection across two decades: a single regional reference center report
|
Ricco, G.
|
|
|
53 |
S1 |
p. S1
|
artikel
|
| 15 |
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma
|
Grossi, I.
|
|
|
53 |
S1 |
p. S38
|
artikel
|
| 16 |
Circulating prostaglandin E2: A novel potential prognostic biomarker in patients with hepatocellular carcinoma
|
Pelizzaro, F.
|
|
|
53 |
S1 |
p. S40
|
artikel
|
| 17 |
Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE)
|
Formentin, C.
|
|
|
53 |
S1 |
p. S7
|
artikel
|
| 18 |
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis
|
Gerussi, A.
|
|
|
53 |
S1 |
p. S5
|
artikel
|
| 19 |
Coagulation balance and liver damage in non-cirrhotic patients with chronic hepatitis C after eradication by Direct-acting Antiviral Agents (DAAs)
|
Sigon, G.
|
|
|
53 |
S1 |
p. S15-S16
|
artikel
|
| 20 |
Comparing surgery versus sorafenib in advanced hepatocellular carcinoma: An Italian weighted study
|
Famularo, S.
|
|
|
53 |
S1 |
p. S41
|
artikel
|
| 21 |
Complete response after biological downstaging in patients with hepatocellular carcinoma: XXL-like prioritization for liver transplantation or “waiting and see” strategy?
|
Scolari, F.
|
|
|
53 |
S1 |
p. S8
|
artikel
|
| 22 |
Copper chelation as a new treatment strategy to counteract hepatocellular carcinoma
|
Santini, S.J.
|
|
|
53 |
S1 |
p. S38-S39
|
artikel
|
| 23 |
Correlation of the transaminases alteration with the clinical severity of patients with COVID- 19: A meta-analysis of the first global outbreak
|
Miele, L.
|
|
|
53 |
S1 |
p. S23
|
artikel
|
| 24 |
COVID-19 and Solid Organ Transplantation (SOT) in Italy: A web-survey
|
Galiandro, F.
|
|
|
53 |
S1 |
p. S45-S46
|
artikel
|
| 25 |
Definition of healthy ranges for alanine aminotransferase levels: a 2020 update
|
Valenti, L.
|
|
|
53 |
S1 |
p. S4
|
artikel
|
| 26 |
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma
|
Campani, C.
|
|
|
53 |
S1 |
p. S40-S41
|
artikel
|
| 27 |
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant)
|
Brodosi, L.
|
|
|
53 |
S1 |
p. S23
|
artikel
|
| 28 |
Editorial Board
|
|
|
|
53 |
S1 |
p. i-ii
|
artikel
|
| 29 |
EILF-Italian migrants study: An HCV and HBV micro elimination pilot project
|
Colucci, G.
|
|
|
53 |
S1 |
p. S20-S21
|
artikel
|
| 30 |
Epidemiological and clinical profile of 302 patients with primary biliary cholangitis in Piedmont and Liguria
|
De Benedittis, C.
|
|
|
53 |
S1 |
p. S18-S19
|
artikel
|
| 31 |
Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: A case series
|
Loglio, A.
|
|
|
53 |
S1 |
p. S17
|
artikel
|
| 32 |
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells
|
Gentilini, A.
|
|
|
53 |
S1 |
p. S6
|
artikel
|
| 33 |
Fatty Acids regulate the biology of cholangiocarcinoma cells
|
Lori, G.
|
|
|
53 |
S1 |
p. S36-S37
|
artikel
|
| 34 |
Ferroptosis in intrahepatic cholangiocarcinoma: an immunohistochemical study
|
Sacchi, D.
|
|
|
53 |
S1 |
p. S6
|
artikel
|
| 35 |
GEMS, a GEnetic and Metabolic Staging predicting the outcome of non-alcoholic fatty liver disease
|
Pennisi, G.
|
|
|
53 |
S1 |
p. S3-S4
|
artikel
|
| 36 |
General Practitioner databaSe NAFLD (GPS-NAFLD) study: Italian regional variability of the NAFLD prevalence rate
|
Miele, L.
|
|
|
53 |
S1 |
p. S30-S31
|
artikel
|
| 37 |
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: prevalence of advanced liver fibrosis among Italian primary care patients with NAFLD
|
Miele, L.
|
|
|
53 |
S1 |
p. S7-S8
|
artikel
|
| 38 |
Hepatocellular carcinoma prognostic scores: A 10 years experience
|
Campigotto, M.
|
|
|
53 |
S1 |
p. S35-S36
|
artikel
|
| 39 |
Hepatocellular liver injury in hospitalized patients affected by COVID-19: Different factors at different time points
|
Leo, M.
|
|
|
53 |
S1 |
p. S21
|
artikel
|
| 40 |
High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients
|
Pelizzaro, F.
|
|
|
53 |
S1 |
p. S22
|
artikel
|
| 41 |
High prevalence of multiple drug resistant bacterial infections in patients with pyogenic liver abscesses following loco regional therapy for liver cancer
|
Colapietro, F.
|
|
|
53 |
S1 |
p. S21
|
artikel
|
| 42 |
Impact of hospital volume on hepatocellular carcinoma survival in Italy
|
Pelizzaro, F.
|
|
|
53 |
S1 |
p. S9-S10
|
artikel
|
| 43 |
Incidence of liver-related events in 647 HCV cirrhotics treated with DAA: A 5-year single center study
|
D'Ambrosio, R.
|
|
|
53 |
S1 |
p. S15
|
artikel
|
| 44 |
Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: A new potential therapeutic target?
|
Zanetto, A.
|
|
|
53 |
S1 |
p. S37-S38
|
artikel
|
| 45 |
Increased serum ferritin levels predict long-term mortality in patients with NAFLD
|
Armandi, A.
|
|
|
53 |
S1 |
p. S28
|
artikel
|
| 46 |
Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?
|
Celsa, C.
|
|
|
53 |
S1 |
p. S33
|
artikel
|
| 47 |
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection
|
Liguori, A.
|
|
|
53 |
S1 |
p. S46-S47
|
artikel
|
| 48 |
Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs
|
Cillo, U.
|
|
|
53 |
S1 |
p. S44
|
artikel
|
| 49 |
Liver transplant candidates and SARS-CoV-2 infection: Results from an Italian multicenter cohort
|
Perricone, G.
|
|
|
53 |
S1 |
p. S45
|
artikel
|
| 50 |
Liver Transplant in Patient with Breast Cancer Liver Metastasis and Hepatic Failure
|
Giannelli, V.
|
|
|
53 |
S1 |
p. S46
|
artikel
|
| 51 |
Liver transplant recipients with Covid-19: results from an Italian multicenter cohort
|
Mazzarelli, C.
|
|
|
53 |
S1 |
p. S13
|
artikel
|
| 52 |
Long-term effective oral therapy could spare endoscopic surveillance of esophageal varices in HBV compensated cirrhotics: a 10-year study
|
Farina, E.
|
|
|
53 |
S1 |
p. S1-S2
|
artikel
|
| 53 |
Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression
|
Bowlus, C.L.
|
|
|
53 |
S1 |
p. S18
|
artikel
|
| 54 |
Metabolic alterations and hepatic fibrosis impact on severity of SARS-COV2 infection
|
Lombardi, R.
|
|
|
53 |
S1 |
p. S4
|
artikel
|
| 55 |
Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology
|
Longo, M.
|
|
|
53 |
S1 |
p. S19
|
artikel
|
| 56 |
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats
|
Filibian, M.
|
|
|
53 |
S1 |
p. S29
|
artikel
|
| 57 |
Modeling hepatocellular carcinoma cells dynamics by serolo-gical and imaging biomarkers in patients with response to sorafenib and/or regorafenib
|
Colombatto, P.
|
|
|
53 |
S1 |
p. S39-S40
|
artikel
|
| 58 |
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study
|
Miele, L.
|
|
|
53 |
S1 |
p. S31-S32
|
artikel
|
| 59 |
New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct-acting antiviral therapy (DAAs) in patients with chronic hepatitis C: Evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM
|
Cespiati, A.
|
|
|
53 |
S1 |
p. S16
|
artikel
|
| 60 |
No impact of the 2020 COVID-19 lockdown on hospitalization rates for alcoholic liver disease in a large tertiary hospital in Milan
|
Masetti, C.
|
|
|
53 |
S1 |
p. S30
|
artikel
|
| 61 |
Non-invasive tests to predict liver-related events in a single-center cohort of 486 HCV cirrhotic patients treated with DAA
|
Degasperi, E.
|
|
|
53 |
S1 |
p. S14-S15
|
artikel
|
| 62 |
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
|
Grimaudo, S.
|
|
|
53 |
S1 |
p. S25
|
artikel
|
| 63 |
Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non-invasive markers of fibrosis: Results of a post hoc analysis from the interim analysis of the REGENERATE study
|
Loomba, R.
|
|
|
53 |
S1 |
p. S26
|
artikel
|
| 64 |
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats
|
Pasqua, L.G. Di
|
|
|
53 |
S1 |
p. S41
|
artikel
|
| 65 |
Oleuropein prevents liver damage in NAFL mice by modulating copper-catalyzed dicarbonyl stress
|
Santini, S.J.
|
|
|
53 |
S1 |
p. S31
|
artikel
|
| 66 |
Outcomes and risk factors for recurrence of disease in adult liver transplantation due to Primary Sclerosing Cholangitis: a single-centre experience
|
Vitale, G.
|
|
|
53 |
S1 |
p. S5-S6
|
artikel
|
| 67 |
Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome
|
Guarino, M.
|
|
|
53 |
S1 |
p. S8-S9
|
artikel
|
| 68 |
Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: Implications for second-line trials
|
Tovoli, F.
|
|
|
53 |
S1 |
p. S19
|
artikel
|
| 69 |
Perfusion analysis with dynamic contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma: A pilot study of a novel parameter aiming to improve the detection of wash-out
|
Mulazzani, L.
|
|
|
53 |
S1 |
p. S34
|
artikel
|
| 70 |
Pilot screening of HBV and HCV prevalence in at risk po-pulations due to geographical origin and conditions of socio-economic distress
|
Lorini, S.
|
|
|
53 |
S1 |
p. S22-S23
|
artikel
|
| 71 |
Pregnancy after liver transplantation: a survey from Italian liver transplants centres
|
Sciarrone, S.S.
|
|
|
53 |
S1 |
p. S12-S13
|
artikel
|
| 72 |
Prevalence and impact on post-transplant outcome of sarcopenia among patients with cirrhosis on waiting-list for liver transplantation: Preliminary data from an Italian single center experience
|
Invernizzi, F.
|
|
|
53 |
S1 |
p. S45
|
artikel
|
| 73 |
Preventing hepatic fibrogenesis with the two extra-virgin olive oil polyphenols tyrosol and hydroxytyrosol via NOX inhibition
|
Gabbia, D.
|
|
|
53 |
S1 |
p. S8
|
artikel
|
| 74 |
Prognostic role of platelets-to lymphocytes ratio (PLR) and neutrophils-to-lymphocytes ratio (NLR) in hepatocellular carcinoma patients
|
Pelizzaro, F.
|
|
|
53 |
S1 |
p. S32-S33
|
artikel
|
| 75 |
Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma
|
Celsa, C.
|
|
|
53 |
S1 |
p. S35
|
artikel
|
| 76 |
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study
|
Avolio, A.W.
|
|
|
53 |
S1 |
p. S44
|
artikel
|
| 77 |
Psychological profiles and risk of relapse in cirrhosis due to alcohol abuse
|
Galeota Lanza, A.
|
|
|
53 |
S1 |
p. S24-S25
|
artikel
|
| 78 |
Rare and common ATG7 variants predispose to severe fatty liver disease
|
Baselli, G.
|
|
|
53 |
S1 |
p. S26-S27
|
artikel
|
| 79 |
Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors
|
Tovoli, F.
|
|
|
53 |
S1 |
p. S10
|
artikel
|
| 80 |
Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
|
Iavarone, M.
|
|
|
53 |
S1 |
p. S11
|
artikel
|
| 81 |
RESIST-HCV criteria are able to rule out esophageal varices progression in patients with HCV cirrhosis treated by Direct-acting Antiviral Agents(DAAs)
|
Calvaruso, V.
|
|
|
53 |
S1 |
p. S6-S7
|
artikel
|
| 82 |
Risk factors for post-banding ulcer bleeding in cirrhotic patients undergoing elective esophageal varices band ligation
|
Tosetti, G.
|
|
|
53 |
S1 |
p. S42
|
artikel
|
| 83 |
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests
|
Alterini, G.
|
|
|
53 |
S1 |
p. S31
|
artikel
|
| 84 |
SIRT5 rs12216101 T>G variant is associated with fibrosis severity in patients with non-alcoholic fatty liver disease
|
Salomone, F.
|
|
|
53 |
S1 |
p. S3
|
artikel
|
| 85 |
Tenofovir Alafenamide improves proximal tubular markers in CHB patients long-term treated with Tenofovir Disoproxil Fumarate: A real-life study based on the EASL switching criteria
|
Loglio, A.
|
|
|
53 |
S1 |
p. S14
|
artikel
|
| 86 |
The best potential treatment for recurrent hepatocellular carcinoma after surgery: a machine learning predictive model for treatment allocation based on an Italian multicentric database
|
Famularo, S.
|
|
|
53 |
S1 |
p. S11-S12
|
artikel
|
| 87 |
The “CASERTA MODEL”: Caserta HCV Free Hospital
|
Messina, V.
|
|
|
53 |
S1 |
p. S16
|
artikel
|
| 88 |
The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19
|
Biliotti, E.
|
|
|
53 |
S1 |
p. S21-S22
|
artikel
|
| 89 |
The impact of a local antibiotic stewardship program: Low rate of spontaneous bacterial peritonitis and bacteriascites sustained by multidrug-resistant organisms
|
Mantovani, A.
|
|
|
53 |
S1 |
p. S42-S43
|
artikel
|
| 90 |
The I148M PNPLA3 variant mitigates Niacin beneficial effects: How the genetic screening in NAFLD patients gains value
|
Paolini, E.
|
|
|
53 |
S1 |
p. S29-S30
|
artikel
|
| 91 |
The protease-inhibitor serpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma
|
Correnti, M.
|
|
|
53 |
S1 |
p. S33-S34
|
artikel
|
| 92 |
The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients
|
Meroni, M.
|
|
|
53 |
S1 |
p. S32
|
artikel
|
| 93 |
The role of variant rs17618244 of KLB gene in MAFLD-related fibrosis
|
Panera, N.
|
|
|
53 |
S1 |
p. S25-S26
|
artikel
|
| 94 |
Thrombocytopenia in chronic liver disease: the analysis of Italian administrative healthcare data by Fondazione RES
|
Dondi, L.
|
|
|
53 |
S1 |
p. S23-S24
|
artikel
|
| 95 |
TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models
|
Longo, M.
|
|
|
53 |
S1 |
p. S27-S28
|
artikel
|
| 96 |
Treatment of CRKP infections in cirrhotic patients
|
Feldman, S.
|
|
|
53 |
S1 |
p. S42
|
artikel
|
| 97 |
Ultrasound guided paracentesis: A study on reproducibility and diagnostic accuracy of a Pocket-size Ultrasound Device (PUD)
|
Costantino, A.
|
|
|
53 |
S1 |
p. S43
|
artikel
|
| 98 |
Whole exome sequencing for the diagnosis of rare genetic conditions in patients with unexplained liver disease and complex clinical presentation
|
Pelusi, S.
|
|
|
53 |
S1 |
p. S20
|
artikel
|
Tijdschrift beschrijving